ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Serono, Pfizer, And Broad Institute Link

by Ann M. Thayer
April 7, 2014 | APPEARED IN VOLUME 92, ISSUE 14

MerckSerono has entered a research collaboration with Pfizer and the Broad Institute in Cambridge, Mass., that will focus on the genomic profiling of systemic lupus erythematosus and lupus nephritis patients. Serono and Pfizer will provide the funding for Broad researchers to analyze clinical samples. They hope to find biomarkers that define patient populations for new therapies. Using computational modeling, the partners also hope to identify molecular drivers of the diseases that might serve as drug targets.

[+]Enlarge
Credit: Broad Institute
A robotics lab at the Broad Institute.
09214-buscon-BroadRoboticslabcxd.jpg
Credit: Broad Institute
A robotics lab at the Broad Institute.
X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment